Bio Break: Why Don’t We Have a Cortisol-Sensing Wearable Yet?

Resources

Bio Break: Why Don’t We Have a Cortisol-Sensing Wearable Yet?

Sector: Wearables
Topic: Bio Break

In this Bio Break episode, Nick Allan and Joris van der Heijden tackle a question many tech and health enthusiasts have wondered for years: Where is my cortisol-sensing wearable? Nick shares a nostalgic story of reading about futuristic wearable technology in Popular Mechanics as a child — devices that would one day monitor biomarkers like cortisol to track stress and overall health. Now, decades later, he and Joris break down why such a wearable device still hasn’t become a reality.

Joris explains that although cortisol biosensors and other advanced wearable diagnostics often show up in academic research, turning those scientific breakthroughs into viable consumer products is a much bigger challenge. First, there’s the technical difficulty of converting a sensitive laboratory assay for cortisol into a fully automated, real-time wearable device that could be used reliably outside of controlled lab settings. Measuring something like cortisol, potentially via interstitial fluid or sweat, involves complex fluidic and sensing systems that must function accurately and consistently on a wearable platform.

Second — and often the biggest hurdle — is scaling up manufacturing. Developing a biosensor consumable that can be produced in the millions, perform reliably for every user, and endure various shipping and environmental conditions is an enormous undertaking. Joris points out that ensuring batch-to-batch consistency for sensitive biological components is one of the toughest parts of commercializing wearable biosensor technology. Add to that the need to meet stringent regulatory standards for medical wearables, and it’s easy to see why many promising lab innovations never make it to market.

In short, the journey from a cortisol-sensing concept to a commercial wearable health device requires not only cutting-edge science but also significant investment, manufacturing expertise, and regulatory strategy.

Why Don’t We Have a Cortisol-Sensing Wearable Yet?

Fluorescent Imaging immunofluorescence of cancer cells growing in 2D with nuclei in blue, cytoplasm in red and DNA damage foci in green

Fluorescence Imaging in Medical Devices outlines medical applications and examples of devices that use fluorescence for imaging.

A composite image showing an eye processed through a sequence of transformations from left to right. The leftmost section displays a relatively clear image of a human eye with natural textures and lashes. Moving right, the image becomes increasingly abstract and pixelated through various digital processing techniques, including edge detection, binarization, contrast enhancement, and pixel block reduction. Each vertical segment represents a different stage or algorithm in the image processing pipeline, transitioning from high-resolution realism to low-resolution abstraction.

Computer Vision for Medical Devices is constantly evolving and incorporating new techniques and technologies as they emerge.

A macro shot of a 3D bioprinter depositing layers of bioink to create tissue constructs for medical research, Bioprinting technology style, photo of

Being able to control the release rate of a target molecule is a valuable tool for engineering tissues and therapeutic delivery of regenerative medicine applications.

A promotional graphic with bold text reading "Vision Surgery with a Tooth" in purple and black letters. Below the text is a large 3D image of a tooth and a purple plus sign. On the right side, a woman is undergoing an eye exam using a slit lamp microscope.

In this episode of Bio Break, Nick and Joris dive into one of the most astonishing—and real—medical innovations we’ve ever come across: osteo-odonto-keratoprosthesis. Or, as Nick quickly dubs it, “tooth in eye surgery.”